Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Estrogenic effect (functional) | = 0 % | Estrogenicity in rats following 3 x 1 mg s.c. over 72h. | ChEMBL. | 2754694 |
Inhibition (functional) | = 0 % | Inhibition of E2 effects in rats by 1 mg s.c. | ChEMBL. | 2754694 |
RBA (binding) | = 1.6 g | Relative binding against estrogen receptor of rat uterine cytosol by [2-4-3H] estradiol. | ChEMBL. | 2754694 |
RBA (binding) | = 1.6 g | Relative binding against estrogen receptor of rat uterine cytosol by [2-4-3H] estradiol. | ChEMBL. | 2754694 |
Uterine weight (functional) | = 14.6 g | Uterotrophic effects in rats following 3 x 1 mg s.c. over 72h. | ChEMBL. | 2754694 |
Uterine weight (functional) | = 46.5 g | Anti-uterotrophic effects in rats following 3 x 1 mg s.c. over 72h. | ChEMBL. | 2754694 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.